This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Barbara A. DeBuono, MD, MPH; H. Denman Scott, MD, MPH; Leonard LaFazia, MS
Michael DiMatteo Rhode Island Department of Health Providence

Kenneth H. Mayer, MD
Memorial Hospital Brown University Program in Medicine Providence, RI

JAMA. 1989;261(17):2502.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor. —

Routine serological screening for human immunodeficiency virus (HIV) infection has been recommended for patients attending sexually transmitted disease (STD) clinics.^1-3 Blinded serological testing of STD clinics' clients can serve as an accurate assessment of seroprevalence in this well-defined population.^3,4

Study.—

In anonymous and blinded screening of 1025 consecutive patients attending Rhode Island state-supported clinics for STDs between January 14 and May 20, 1988, we found an HIV seroprevalence rate of 3.1%. The clinic serves an urban population. Two thirds of the study population were men and one third were women. Of the 32 HIV-seropositive clients, 29 (91%) were men and only 3 (9%) were women. Seroprevalence in men was higher than that in women, 4% vs 1%. The age distribution of HIV-positive clients (median age, 32 years) was older than that of the study population (median age, 27 years). The median age of HIV-positive . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?